Empowered Relief® Chronic Pain Management Program Highlighted in New LVHN Video

Steph Penny says "You Can Survive Chronic Illness"

Will U.S. Have Enough Pain Specialists?

NaHS modulates astrocytic EAAT2 expression to impact SNI-induced neuropathic pain and depressive-like behaviors

PGI pioneers yoga therapy for chronic back pain

Tris Pharma Announces Positive Results from ALLEVIATE-1 Phase 3 Clinical Trial of Cebranopadol, an Investigational First-in-Class Oral Dual-NMR Agonist, for the Treatment of Moderate-to-Severe Acute Pain

Scilex Holding Company Announces that the U.S. FDA Has Acknowledged the Submission of Our Supplemental New Drug Application for ELYXYB® in Acute Pain Indication

Cullgen Begins Phase 1 Dosing of its Potential First-in-Class, Oral Pan-TRK Protein Degrader for Acute and Chronic Pain

IMMvention Therapeutix Enters Strategic Collaboration with

FDA grants MRI conditional label extension for Nalu Medical’s neurostimulation system